Clinical Trial Update: Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis [NA]

View source ↗

Summary

A completed clinical trial comparing sincalide (cholecystokinin octapeptide) to placebo in high-risk neonates to assess prevention of parenteral nutrition-assoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis
• Parenteral Nutrition Associated Cholestasis

Drugs mentioned

• Sincalide (sincalide)

Snippet

Sponsor: University of Michigan | Conditions: Cholestasis | NA | Status: COMPLETED